19体育官网app下载

MitoCluster

World-leading consortium focused on mitochondrial dysfunction

Published on: 19 April 2022

Experts at 19体育 are part of a £2.93 million world-leading consortium focused on human conditions linked to mitochondrial dysfunction.

一个来自 Wellcome Centre for 线粒体l 研究 is one of seven cluster groups within the new Medical 研究 Council’s (MRC) National Mouse Genetics Network.

的 aim of the groups is to realise the potential of complex genetic engineered mouse models in predicting therapies for human diseases and advancing medical treatments.

mitochondria standard image right
线粒体

Focus of Newcastle scientists

劳拉·格里夫斯博士, Dr Jim Stewart and Professor Bobby McFarland are the experts involved in the 19体育 MitoCluster.

麦克法兰教授 said: “From a clinical perspective, the creation and meticulous assessment of mitochondrial mouse models will be invaluable, allowing us to develop and test treatments for mitochondrial disease and related disorders; an area that we are intensely focused on in Newcastle.”

线粒体 are tiny energy generators that exist in large numbers inside human cells. A large group of genetic disorders, called primary mitochondrial diseases (PMDs), and many common conditions, including 癌症 和老年痴呆症, are linked to faulty mitochondria.

的 MitoCluster will connect world-leading expertise in PMDs, 线粒体生物学, and mouse models from universities across the country.

的 consortium will undertake research in mice to better understand how and why faulty mitochondria cause human diseases, while finding new ways to measure these disorders over time and developing new treatments that will progress to human trials in the future.

斯图尔特博士 said: “More models are clearly needed to understand the basic mechanisms of mitochondrial disease to address these diverse and debilitating disorders.”

Recent mitochondrial research by the UK’s Mary Lyon Centre has developed advances in techniques to monitor remotely any subtle changes in mouse development, 运动, and behaviour in their “home cage” environment - this will allow the MitoCluster team to study key aspects of these conditions in mice more accurately and humanely.

格里夫斯博士 added: “Being part of the MRC National Mouse Genetics Network will also allow us to work with world-leading experts to elucidate the roles of mitochondrial dysfunction in more common diseases.”

MRC集群主题

MRC National Mouse Genetics Network is a major new £22 million investment in mouse genetics for disease modelling that will capitalise on the UK’s international excellence in the biomedical sciences.

的 Network is comprised of seven challenge-led research clusters, with members distributed across the UK, and these include research areas such as 癌症, congenital anomalies and microbiome.

罗伯特博士Pitceathly, MitoCluster铅, said: “Our MRC award will help us better understand diseases linked with mitochondrial dysfunction, including mitochondrial diseases, 癌症, 和老年痴呆症.

“Ultimately, our aim is to develop treatments for these disorders. We are also looking forward to working closely with the Mary Lyon Centre at MRC Harwell, and with other colleagues across the MRC National Mouse Genetics Network as part of this exciting initiative.”

分享:




最新消息